This strategic expansion represents a significant... 10 nov 2024 Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback